These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 3028314)

  • 1. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
    Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preneoplastic lesions in chronic hepatitis C.
    Thung SN; Hytiroglou P; Fiel I; Theise N
    Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-cell dysplasia and hepatocellular carcinoma.
    Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
    Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preneoplastic conditions of the liver.
    Riegler JL
    Semin Gastrointest Dis; 1996 Apr; 7(2):74-87. PubMed ID: 8705261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma.
    Kojiro M; Shimamatsu K; Kage M
    Princess Takamatsu Symp; 1995; 25():179-84. PubMed ID: 8875623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
    Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
    Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-A, non-B hepatitis: characterization of liver biopsy pathology.
    Lefkowitch JH; Apfelbaum TF
    J Clin Gastroenterol; 1989 Apr; 11(2):225-32. PubMed ID: 2500477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic cell dysplasia. A pre-malignant lesion related to hepatocellular carcinoma and infection by hepatitis B virus].
    de Queiroz AC; Moreira DE; Andrade ML
    Arq Gastroenterol; 1987; 24(2):80-3. PubMed ID: 2849924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The progression of non-A, non-B hepatitis to chronic diseases, and the transformation to hepatocellular carcinoma].
    Ichida T; Ichida F
    Nihon Rinsho; 1988 Dec; 46(12):2669-75. PubMed ID: 2853799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
    Feng Z; He R; Lu Z; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large liver cell dysplasia: a controversial entity.
    Park YN; Roncalli M
    J Hepatol; 2006 Nov; 45(5):734-43. PubMed ID: 16982109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K; Akahane Y; Nagata A; Furuta S
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.